SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Patent Office has granted Patent Number 11,357,463: titled, “Target Site Selection, Entry and Update With Automatic Remote Image Annotation”, with a patent term that will expire in late 2034.
‘Tesla Model Y Performance nearly sold out for 2021’ -Teslarati
https://www.teslarati.com/tesla-model-y-performance-2021-sell-out-near/
